We have an important update on the compounded, generic Versions of Mounjaro and Zepbound, Tirzepatide:
The generic version of Mounjaro and Zepbound also called Tirzepatide, which are currently being allowed by the FDA to be compounded by some compounding pharmacies, will be taken off the list of drugs in short supply as of December 2024. They will become unavailable for purchase by the general public.
What will change: Only the brand names of these drugs will be available! And, these drugs are expensive if not covered by insurance.
What to do: If you are interested in these drugs, you need to contact us to stock up on Tirzepatide, Mounjaro and Zepbound before December 2024!
Why They Work for Weight Loss: Semaglutide and Tirzepatide the compounds in Ozempic, Wegovy, Zepbound and Mounjaro also known as glucagon-like peptide-1 receptor agonists(GLP-1) are a class of medications originally developed for the treatment of type 2 diabetes. They have shown promise in managing various other health conditions due to their wide-ranging effects on metabolism, appetite, and insulin sensitivity.
Interested in Tirzepatide, Moujaro, Zepbound, or Semaglutide? Call us for a referral: 770-635-7607